4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-003822
Options or other derivatives
- Chief Operating Officer returned 8,500 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Linscott Walt Addison · Chief Operating Officer
Table II: Derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-10 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −1,750 | $0.06 | $103 | 0 | D |
| 2025-04-10 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −750 | $0.06 | $44 | 0 | D |
| 2025-04-10 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −1,250 | $0.06 | $74 | 0 | D |
| 2025-04-10 | Returned to the company : show line 4 in the form Stock Option (right to buy) | −1,125 | $0.06 | $66 | 0 | D |
| 2025-04-10 | Returned to the company : show line 5 in the form Stock Option (right to buy) | −2,500 | $0.06 | $148 | 0 | D |
| 2025-04-10 | Returned to the company : show line 6 in the form Stock Option (right to buy) | −1,125 | $0.06 | $66 | 0 | D |
Loading xslF345X05/ownership.xml…